Keyphrases
Everolimus
100%
Squamous Cell Carcinoma (SqCC)
100%
In Vivo Growth
100%
SCCVII
100%
Pulmonary Metastasis
55%
Twice a Day
44%
Tumor Inhibition
33%
Tumor
22%
Cyclosporine
22%
Tumor Metastasis
22%
Efficacy Study
11%
Immunosuppression
11%
Transplant Recipients
11%
Malignancy
11%
Intravenous Injection
11%
Disease Spread
11%
Tumor Growth
11%
Study Support
11%
Murine Model
11%
MTOR Inhibitor
11%
Rapamycin
11%
Intradermal Injection
11%
Trough Level
11%
Immunosuppressive Agents
11%
Neoplastic Disease
11%
Laryngectomy
11%
Laryngeal Transplantation
11%
Antineoplastic Properties
11%
Prior Malignancy
11%
Medicine and Dentistry
Squamous Cell Carcinoma
100%
Everolimus
100%
Lung Metastasis
55%
Neoplasm
33%
Cancer Inhibition
33%
Cancer
22%
Metastatic Carcinoma
22%
Cyclosporine
22%
Immunosuppressive Drug
22%
Disease
11%
Transplantation
11%
Anticarcinogen
11%
Intravenous Drug Administration
11%
Tumor Progression
11%
Drug Therapy
11%
Efficacy Study
11%
Immunosuppressive Treatment
11%
Rapamycin
11%
Intradermal Drug Administration
11%
Mammalian Target of Rapamycin Inhibitor
11%
Laryngectomy
11%
Trough Level
11%
Pharmacology, Toxicology and Pharmaceutical Science
Everolimus
100%
Squamous Cell Carcinoma
100%
Lung Metastasis
55%
Cancer Inhibition
33%
Neoplasm
33%
Metastasis
22%
Ciclosporin
22%
Immunosuppressive Agent
22%
Mouse
11%
Efficacy Study
11%
Anticarcinogen
11%
Tumor Growth
11%
Mammalian Target of Rapamycin Inhibitor
11%
Trough Level
11%
Disease
11%
Rapamycin
11%